Cost-effectiveness of an in-development adult-formulated pneumococcal vaccine in older US adults. [PDF]
Wateska AR +6 more
europepmc +1 more source
Specific Features of Immune Response in Patients with Different Asthma Endotypes Following Immunization with a Conjugate Pneumococcal Vaccine. [PDF]
Kostinov AM +9 more
europepmc +1 more source
Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023. [PDF]
Kobayashi M +11 more
europepmc +1 more source
Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly
Ger T. Rijkers +3 more
openalex +2 more sources
Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. [PDF]
Solomon Langermann +6 more
openalex +1 more source
Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. <i>Vaccines</i> 2024, <i>12</i>, 974. [PDF]
Feemster K +8 more
europepmc +1 more source
State of pneumococcal vaccine immunity. [PDF]
Akkoyunlu M.
europepmc +1 more source
Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines [PDF]
Hyunju Lee, Eun Hwa Choi, Hoan Jong Lee
openalex +1 more source

